| Title: |
Graphene oxide topical administration: Skin permeability studies |
| Authors: |
Silva, FALS; Costa-Almeida, R; Timochenco, L; Amaral, SI; Pinto, S; Gonçalves, IC; Fernandes, JR; Magalhães, FD; Sarmento, B; Pinto, AM |
| Contributors: |
Instituto de Investigação e Inovação em Saúde |
| Publisher Information: |
MDPI |
| Publication Year: |
2021 |
| Collection: |
Repositório Aberto da Universidade do Porto |
| Subject Terms: |
Biocompatibility; Carbon nanomaterials; Graphite; Phototherapy; Skin disease |
| Description: |
Nanostructured carriers have been widely used in pharmaceutical formulations for der-matological treatment. They offer targeted drug delivery, sustained release, improved biostability, and low toxicity, usually presenting advantages over conventional formulations. Due to its large surface area, small size and photothermal properties, graphene oxide (GO) has the potential to be used for such applications. Nanographene oxide (GOn) presented average sizes of 197.6 ± 11.8 nm, and a surface charge of -39.4 ± 1.8 mV, being stable in water for over 6 months. 55.5% of the mass of GOn dispersion (at a concentration of 1000 µg mL-1 ) permeated the skin after 6 h of exposure. GOn dispersions have been shown to absorb near-infrared radiation, reaching temperatures up to 45.7¿ C, within mild the photothermal therapy temperature range. Furthermore, GOn in amounts superior to those which could permeate the skin were shown not to affect human skin fibroblasts (HFF-1) morphology or viability, after 24 h of incubation. Due to its large size, no skin permeation was observed for graphite particles in aqueous dispersions stabilized with Pluronic P-123 (Gt–P-123). Altogether, for the first time, Gon’s potential as a topic administration agent and for delivery of photothermal therapy has been demonstrated. ; This work was financed by FEDER funds through the COMPETE 2020–Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by national funds (PIDDAC) through FCT/MCTES in the framework of the project POCI-01-0145-FEDER-031143, and Base Funding-UIDB/00511/2020 of the Laboratory for Process Engineering, Environment, Biotechnology and Energy–LEPABE. Additional funding included FCT/MCTES in the framework of the project “Institute for Research and Innovation in Health Sciences” (UID/BIM/04293/2019). Authors would also like to thank the support of i3S Scientific Platforms and respective funding: HEMS, member of the national infrastructure PPBI–Portuguese Platform of Bioimaging: ... |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/pdf |
| Language: |
English |
| Relation: |
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00511%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FBIM%2F04293%2F2019/PT; info:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F144719%2F2019/PT; Materials, vol.14(11):2810; https://www.mdpi.com/1996-1944/14/11/2810; https://hdl.handle.net/10216/152522 |
| DOI: |
10.3390/ma14112810 |
| Availability: |
https://hdl.handle.net/10216/152522; https://doi.org/10.3390/ma14112810 |
| Rights: |
info:eu-repo/semantics/openAccess |
| Accession Number: |
edsbas.5FC7D631 |
| Database: |
BASE |